Literature DB >> 20201954

"Transcription physiology" of pigment formation in melanocytes: central role of MITF.

Jiri Vachtenheim1, Jan Borovanský.   

Abstract

Melanin production is the primary mechanism protecting human skin against the UV light-induced damage. The polymeric compound melanin is synthesized within melanocytes in the specialized subcellular organelles, termed melanosomes, which are then transferred to surrounding keratinocytes. The genes for melanin synthesis and deposition are coordinately expressed in melanocytes. The transcription factor MITF, which has been reported to activate more than 25 genes in pigment cells, has emerged as an essential regulator not only for melanocyte development, proliferation and survival, but also for the expression of enzymes and structural proteins ensuring the production of melanin. MITF is a transcriptional activator of several genes which encode melanosome-localized proteins involved both in melanin synthesis and in melanosome biogenesis and transport, including genes whose mutations are associated with human oculocutaneous and ocular forms of albinism. Here, we outline the mechanisms of transcriptional regulation of genes associated with the biosynthesis of melanin in melanocytes and melanoma cells. MITF is crucial in this process, while several other factors seem to have only an auxiliary role to play under specific circumstances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201954     DOI: 10.1111/j.1600-0625.2009.01053.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  107 in total

1.  Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.

Authors:  Gulsun Erdag; Jochen T Schaefer; Mark E Smolkin; Donna H Deacon; Sofia M Shea; Lynn T Dengel; James W Patterson; Craig L Slingluff
Journal:  Cancer Res       Date:  2012-01-19       Impact factor: 12.701

2.  Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo.

Authors:  Q Shi; W Zhang; S Guo; Z Jian; S Li; K Li; R Ge; W Dai; G Wang; T Gao; C Li
Journal:  Cell Death Differ       Date:  2015-08-28       Impact factor: 15.828

3.  The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.

Authors:  Youjun Chen; Cecile Chalouni; Christine Tan; Robyn Clark; Rayna Venook; Rachana Ohri; Helga Raab; Ron Firestein; William Mallet; Paul Polakis
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

4.  Downregulation of melanocyte-specific facultative melanogenesis by 4-hydroxy-3-methoxycinnamaldehyde acting as a cAMP antagonist.

Authors:  Eunmiri Roh; In-Yeong Jeong; Hyoeun Shin; Sukgil Song; Nam Doo Kim; Sang-Hun Jung; Jin Tae Hong; Seung Ho Lee; Sang-Bae Han; Youngsoo Kim
Journal:  J Invest Dermatol       Date:  2013-08-07       Impact factor: 8.551

5.  Role of TRPM in melanocytes and melanoma.

Authors:  Huazhang Guo; John Andrew Carlson; Andrzej Slominski
Journal:  Exp Dermatol       Date:  2012-09       Impact factor: 3.960

Review 6.  Regulation of melanocyte stem cells in the pigmentation of skin and its appendages: Biological patterning and therapeutic potentials.

Authors:  Weiming Qiu; Cheng-Ming Chuong; Mingxing Lei
Journal:  Exp Dermatol       Date:  2019-01-15       Impact factor: 3.960

7.  Stress chaperone mortalin regulates human melanogenesis.

Authors:  Renu Wadhwa; Didik Priyandoko; Ran Gao; Nashi Widodo; Nupur Nigam; Ling Li; Hyo Min Ahn; Chae-Ok Yun; Nobuhiro Ando; Christian Mahe; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2016-04-07       Impact factor: 3.667

8.  Docosahexaenoic acid inhibits melanin synthesis in murine melanoma cells in vitro through increasing tyrosinase degradation.

Authors:  Marie Carmel Balcos; Su Yeon Kim; Hyo-soon Jeong; Hye-young Yun; Kwang Jin Baek; Nyoun Soo Kwon; Kyoung-chan Park; Dong-seok Kim
Journal:  Acta Pharmacol Sin       Date:  2014-02-24       Impact factor: 6.150

9.  Melanogenesis inhibition in mice using a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser: a pilot study.

Authors:  Jae-Hui Nam; Joon Hong Min; Wang-Kyun Kim; Sunmin Yim; Won-Serk Kim
Journal:  Lasers Med Sci       Date:  2017-04-20       Impact factor: 3.161

10.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.